Singh, J. C., Mamtani, A., Barrio, A., Morrow, M., Sugarman, S., Jones, L. W., . . . Dang, C. (2017). Pathologic Complete Response with Neoadjuvant Doxorubicin and Cyclophosphamide Followed by Paclitaxel with Trastuzumab and Pertuzumab in Patients with HER2‐Positive Early Stage Breast Cancer: A Single Center Experience. Oncologist.
シカゴスタイル引用形Singh, Jasmeet C., et al. "Pathologic Complete Response With Neoadjuvant Doxorubicin and Cyclophosphamide Followed By Paclitaxel With Trastuzumab and Pertuzumab in Patients With HER2‐Positive Early Stage Breast Cancer: A Single Center Experience." Oncologist 2017.
MLA引用形式Singh, Jasmeet C., et al. "Pathologic Complete Response With Neoadjuvant Doxorubicin and Cyclophosphamide Followed By Paclitaxel With Trastuzumab and Pertuzumab in Patients With HER2‐Positive Early Stage Breast Cancer: A Single Center Experience." Oncologist 2017.